:: Avemar approved for cancer patients ::

Product information	»
Mode of action	»
Preclinical results	»
Clinical oncological effects	»
Frequently asked questions	»
References	»

Publication update
J. Pediatr Hematol Oncol. (10: 631-635. October 2004.) "Fermented wheat germ extract reduces chemo-therapy induced febrile neutropenia in pediatric cancer patients" Download (.pdf)
British Journal of Cancer (89: 465-469, 2003.) "A medical nutriment has supportive value in the treatment of colorectal cancer" Download (.pdf)
Journal of Biololgical Chemistry (277: 46408-46414, 2002.) "Fermented wheat germ extract inhibits glycolysis/pentose cycle enzymes and induces apoptosis through poly(ADP-ribose) polymerase activation in Jurkat T-cell leukemia tumor cells." Download (.pdf) (-->)

Review
THE PRODUCT AND ITS REGISTRATION STATUS Avemar (medical nutriment for cancer patients) is a mixture of molecules with a standardized composition derived from chemically modified natural materials. » More

Who is Who?
List of researchers and contributors participating in the Avemar Research Project. » All researchers

Product information
Indications: Avemar is a medical nutriment for complementing cancer treatment during and after surgery, radiotherapy, chemotherapy and immune therapy. » More

Preclinical results
From the inhibition of metastases to the prevention of cancer. "Avemar... great value in future cancer treatment protocols." (Nature Biotechnology) » More

Mode of action
The facts lying behind Avemar's efficacy. "Individual components of fermented wheat germ (Avemar) may be important anticancer natural drugs both as nutritional supplements and as therapeutic agents..." (Journal of Biological Chemistry) » More

Clinical oncological effects
Increasing the likelihood of survival, inhibiting progression and improving the quality of life. "A medical nutriment (Avemar) has supportive value in the treatment of colorectal cancer" (British Journal of Cancer) » More